| Term 
 
        | What are risk factors for breast cancer? |  | Definition 
 
        | - Gender - female - Age - older
 - Hormones - early period or late menopause. Use of HRT
 - Genetics - p53, HER2, BRCA1/2
 - ALCOHOL INCREASES RISK
 |  | 
        |  | 
        
        | Term 
 
        | What tools assess risk of breast cancer? |  | Definition 
 
        | - Gail model - Claus model
 - BRCAPRO
 |  | 
        |  | 
        
        | Term 
 
        | How is screening for breast cancer completed? |  | Definition 
 
        | - Exams - self exam once a month, clinical starting at age 20 every 1-3 years - Mammogram - 40+ once yearly
 - Breast MRI - high risk patients
 |  | 
        |  | 
        
        | Term 
 
        | How can breast cancer be prevented? |  | Definition 
 
        | - Tamoxifen - ER+, increases endometrial cancers and VTE - Raloxifene - only in post menopausal women. Less risk of VTE
 - Mastectomy
 |  | 
        |  | 
        
        | Term 
 
        | What are types of non-invasive breast cancer? |  | Definition 
 
        | - Ductal carcinoma in situ (DCIS) -15-50% progress to invasive, stays unilateral - Lobular carcinoma in situ (LCIS) - rarely progresses, can affect both breasts
 **basement membrane is still intact
 |  | 
        |  | 
        
        | Term 
 
        | What are types of invasive breast cancer? |  | Definition 
 
        | - Invasive ductal carcinoma (IDC)- most common, worse prognosis. Metastasis to liver, lung, bone - Invasive lobular carcinoma (ILC) - harder to detect, metastasis to retroperitoneal
 |  | 
        |  | 
        
        | Term 
 
        | How does breast cancer present? |  | Definition 
 
        | - Most common: painless mass - palpable lymph nodes
 - High CEA indicates disease
 |  | 
        |  | 
        
        | Term 
 
        | What receptors are on breast cancer cells? |  | Definition 
 
        | - Estrogen receptor - Progesterone receptor
 - HER2 receptor - must be + to benefit from HER2 therapy
 |  | 
        |  | 
        
        | Term 
 
        | What is staging for breast cancer? |  | Definition 
 
        | TNM:based on tumor size, nodal progression, and metastasis |  | 
        |  | 
        
        | Term 
 
        | What determines breast cancer prognosis? |  | Definition 
 
        | - Tumor size - Nodal involvement
 - Young women, african americans have more aggressive disease
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Unique to breast cancer: - Low < 18: low risk of recurrance w/ solo endocrine therapy. Avoid adjuvant chemo
 - Intermediate 18-30 - personal decision
 - High > 31 - high risk of recurrence despite endocrine, adjuvant chemo needed
 |  | 
        |  | 
        
        | Term 
 
        | What is a sentinel lymph node biopsy? |  | Definition 
 
        | Dye injected near tumor, 1st lymph node to take up dye is removed |  | 
        |  | 
        
        | Term 
 
        | How is LCIS and DCIS treated? |  | Definition 
 
        | - LCIS - observation alone. - DCIS - Surgery with or without radiation. Tamoxifen only in lumpectomy patients for ER+ tumors
 |  | 
        |  | 
        
        | Term 
 
        | What is the treatment for Early stage (I,II) breast cancer? |  | Definition 
 
        | - Surgery with or without radiation - T = 0.6- 1 cm - Adjuvant endocrine + chemo, HER2+ add trastuzumab
 - T = >1 - Endocrine + chemo + trastuzumab
 **ER1 - do not use endocrine therapy
 |  | 
        |  | 
        
        | Term 
 
        | When is endocrine therapy warrented in breast cancer? |  | Definition 
 
        | In hormone receptor (+) tumors: - Tamoxifen - SERM, gold standard
 - Aromatase inhibitor: post menopausal only. Anastrazole, letrozole, Exemestane. FOR 5 YEARS
 **Do not give concurrently w/ chemo
 |  | 
        |  | 
        
        | Term 
 
        | What are the cornerstones of breast cancer chemotherapy? |  | Definition 
 
        | Anthracyclines and taxanes within 12 weeks of surgery - HER2(-) - dose dense doxorubicin + cyclophosphamide --> paclitaxel
 - HER2(+) - Paclitaxel + cyclophosphamide + trastuzumab
 |  | 
        |  | 
        
        | Term 
 
        | What therapy should be given to HER2+ breast cancers? |  | Definition 
 
        | Trastuzumab/Herceptin - for all HER2+ over 1 cm |  | 
        |  | 
        
        | Term 
 
        | What is a therapy for metastatic breast cancer in post menopausal women? |  | Definition 
 
        | Exemestane + Everolimus - mTOR inhibitor |  | 
        |  | 
        
        | Term 
 
        | What is 1st line therapy for metastatic Her2+ breast cancer? |  | Definition 
 
        | Pertuzumab + Trastuzumab + Paclitaxel |  | 
        |  | 
        
        | Term 
 
        | What are the side effects of endocrine therapy in breast cancer? |  | Definition 
 
        | Hot flashes and fatigue: tx = Effexor ER 75 qd AI: myalgias and arthralgias. Give vit D and calcium supplements
 |  | 
        |  | 
        
        | Term 
 
        | What are side effects of anthracyclines used in breast cancer? |  | Definition 
 
        | Cardiotoxicity - Dexrazoxane decr toxicity. Alopecia
 N/V
 |  | 
        |  | 
        
        | Term 
 
        | When can eribulin be used for breast cancer? |  | Definition 
 
        | Failure of 2 chemo regimens for metastatic disease **Ixabepilone: for tx failure
 |  | 
        |  | 
        
        | Term 
 
        | What biologics can be used for breast cancer? |  | Definition 
 
        | - Trastuzumab - for HER2+. Infusion rxns and cardiotoxic - Pertuzumab - prevents dimerization
 - Ado-trastuzumab - HER2 + microtubule
 - Lapatinib - kinase inhibitor of EGFR and HER2
 |  | 
        |  |